Atossa logo and header

Clinical Trials to Prevent Breast Cancer

Atossa Genetics believes the future of breast health maintenance goes beyond Diagnosis and Treatment to Identify and Intervene.

Through NAF cytology and molecular diagnostic testing we believe we will be able to identify women at risk of developing cancer years ahead of time. Once identified, these women can be watched more closely and frequently.

More importantly, pharmaceuticals, lifestyle changes including diet, and even dietary supplements may prove able to reverse early precancerous changes and actually prevent the occurrence of breast cancer.

Below you will find selected Breast Cancer Prevention Clinical Trials that have been registered with the US National Institutes of Health. Click on the hyperlink to learn more and then talk with your healthcare provider about what’s right for you.

Breast Cancer Prevention Education

February 17, 2011 - Recruiting - view on ClinicalTrials.gov

Study of Breast Cancer Prevention by Letrozole in High Risk Women

April 11, 2013 - Recruiting - view on ClinicalTrials.gov

Prevention of Breast Cancer: As Simple as hCG-A Randomized Clinical Trial in High Risk Women

December 15, 2008 - Recruiting - view on ClinicalTrials.gov

Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors

January 14, 2013 - Recruiting - view on ClinicalTrials.gov

Fenretinide in Healthy Young Women at Genetic and Familial Risk

September 10, 2012 - Recruiting - view on ClinicalTrials.gov

Vitamin D and Mammographic Breast Density

December 11, 2012 - Recruiting - view on ClinicalTrials.gov

Statins and Breast Cancer Biomarkers

February 10, 2010 - Recruiting - view on ClinicalTrials.gov

Flaxseed in Preventing Breast Cancer in Premenopausal Women at Risk of Developing Breast Cancer

April 8, 2013 - Recruiting - view on ClinicalTrials.gov

My Lifestyle Intervention of Food and Exercise

December 4, 2012 - Recruiting - view on ClinicalTrials.gov

Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 Mutation

July 20, 2012 - Recruiting - view on ClinicalTrials.gov